„Incredibly supportive “
Iris Kuss
Metropolregion Berlin/Brandenburg
517 Follower:innen
500 Kontakte
Metropolregion Berlin/Brandenburg
517 Follower:innen
500 Kontakte
Aktivitäten
-
Manchmal fühlt sich das Leben an, wie eine Reihe verpasster Möglichkeiten. Gestern haben wir uns verlaufen, Worte gesagt, die wir nicht meinten…
Manchmal fühlt sich das Leben an, wie eine Reihe verpasster Möglichkeiten. Gestern haben wir uns verlaufen, Worte gesagt, die wir nicht meinten…
Beliebt bei Iris Kuss
-
𝐈𝐜𝐡 𝐥𝐢𝐞𝐛𝐞 𝐝𝐢𝐞𝐬𝐞𝐬 𝐁𝐢𝐥𝐝. Als der 72-jährige Buchhändler Mohammad Aziz aus Rabat in Marokko gefragt wurde, warum er seine Bücher nach…
𝐈𝐜𝐡 𝐥𝐢𝐞𝐛𝐞 𝐝𝐢𝐞𝐬𝐞𝐬 𝐁𝐢𝐥𝐝. Als der 72-jährige Buchhändler Mohammad Aziz aus Rabat in Marokko gefragt wurde, warum er seine Bücher nach…
Beliebt bei Iris Kuss
-
This was my last day at Bayer before new adventures. Thank you for these six years to all the amazing colleagues!
This was my last day at Bayer before new adventures. Thank you for these six years to all the amazing colleagues!
Beliebt bei Iris Kuss
Berufserfahrung
-
Bayer AG
-
-
-
-
-
-
-
-
Ausbildung
Erhaltene Empfehlungen
1 Person hat Iris Kuss empfohlen
Jetzt anmelden und ansehenWeitere Aktivitäten von Iris Kuss
-
#TeamBayer is proud to announce our collaboration with Microsoft and healthcare professionals from across our region EMEA I. Under the umbrella of…
#TeamBayer is proud to announce our collaboration with Microsoft and healthcare professionals from across our region EMEA I. Under the umbrella of…
Beliebt bei Iris Kuss
-
Patient surveys can lead to many great outcomes, if done well. Are you asking the right questions? .... Creating a patient, or HCP, survey may seem…
Patient surveys can lead to many great outcomes, if done well. Are you asking the right questions? .... Creating a patient, or HCP, survey may seem…
Beliebt bei Iris Kuss
-
#News from our Phase III trial in patients with metastatic hormone-sensitive prostate cancer 📢 The trial met its primary endpoint. #ProstateCancer
#News from our Phase III trial in patients with metastatic hormone-sensitive prostate cancer 📢 The trial met its primary endpoint. #ProstateCancer
Beliebt bei Iris Kuss
-
EORTC is pleased to announce that the primary endpoint has been reached in the EORTC-1333-GUCG/PEACE III Trial.
EORTC is pleased to announce that the primary endpoint has been reached in the EORTC-1333-GUCG/PEACE III Trial.
Beliebt bei Iris Kuss
-
#NEWS We are pleased to announce topline results from a Phase III trial in men with metastatic hormone-sensitive #ProstateCancer…
#NEWS We are pleased to announce topline results from a Phase III trial in men with metastatic hormone-sensitive #ProstateCancer…
Beliebt bei Iris Kuss
-
As I sit here reflecting on my journey in oncology, I can't help but think of the loved ones who inspired me to pursue this path. My parents and best…
As I sit here reflecting on my journey in oncology, I can't help but think of the loved ones who inspired me to pursue this path. My parents and best…
Beliebt bei Iris Kuss
-
Just got back from NEXT Pharma! It was an incredible conference with amazing panelists, speakers, and topics. Here are the key takeaways: - AI and…
Just got back from NEXT Pharma! It was an incredible conference with amazing panelists, speakers, and topics. Here are the key takeaways: - AI and…
Beliebt bei Iris Kuss
-
Studies show that 80% of women going through menopause experience hot flashes. We all have important women in our lives and disruptive symptoms, like…
Studies show that 80% of women going through menopause experience hot flashes. We all have important women in our lives and disruptive symptoms, like…
Beliebt bei Iris Kuss
-
Besides all medical and technical advances, it all comes down to understanding patients as individuell beings requiring personalized attention as…
Besides all medical and technical advances, it all comes down to understanding patients as individuell beings requiring personalized attention as…
Beliebt bei Iris Kuss
-
I was delighted to have been invited to speak on a Research and Development panel with Bayer | Pharmaceuticals, last Tuesday in Berlin. I spoke…
I was delighted to have been invited to speak on a Research and Development panel with Bayer | Pharmaceuticals, last Tuesday in Berlin. I spoke…
Beliebt bei Iris Kuss
-
Darolutamide and PSA in Arasens - just published : https://lnkd.in/dFNv5-nf
Darolutamide and PSA in Arasens - just published : https://lnkd.in/dFNv5-nf
Beliebt bei Iris Kuss
-
Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy and Docetaxel in Black Patients From the Randomized ARASENS Trial
Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy and Docetaxel in Black Patients From the Randomized ARASENS Trial
Beliebt bei Iris Kuss
-
👏 Félicitations au Pr Karim Fizazi, oncologue médical à Gustave Roussy et spécialiste de la prise en charge du cancer de la prostate et du…
👏 Félicitations au Pr Karim Fizazi, oncologue médical à Gustave Roussy et spécialiste de la prise en charge du cancer de la prostate et du…
Beliebt bei Iris Kuss
-
It was great to meet all European colleagues again to celebrate our recent success and prepare for the next indication of Darolutamide to come! Stay…
It was great to meet all European colleagues again to celebrate our recent success and prepare for the next indication of Darolutamide to come! Stay…
Beliebt bei Iris Kuss
-
We are excited to announce that Bayer won a Driving Health Equity Award at the Reuters Events Pharma Awards USA 2024 🏆 for its project improving…
We are excited to announce that Bayer won a Driving Health Equity Award at the Reuters Events Pharma Awards USA 2024 🏆 for its project improving…
Beliebt bei Iris Kuss
-
Recent research among men with prostate cancer has shown that fatigue and other treatment side effects can negatively impact quality of life.…
Recent research among men with prostate cancer has shown that fatigue and other treatment side effects can negatively impact quality of life.…
Beliebt bei Iris Kuss
